Total Payments
$8,065
2024 Payments
$887.65
Companies
42
Transactions
641
Medicare Patients
10,979
Medicare Billing
$627,164
Payment Breakdown by Category
Food & Beverage$8,015 (99.4%)
Education$49.90 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,015 | 638 | 99.4% |
| Education | $49.90 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,129 | 104 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $832.24 | 65 | $0 (2024) |
| Novo Nordisk Inc | $688.63 | 94 | $0 (2023) |
| Lilly USA, LLC | $634.32 | 46 | $0 (2024) |
| PFIZER INC. | $621.55 | 50 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $454.88 | 33 | $0 (2024) |
| Merck Sharp & Dohme LLC | $372.47 | 30 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $360.58 | 25 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $335.65 | 16 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $333.90 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $887.65 | 54 | Bayer Healthcare Pharmaceuticals Inc. ($187.06) |
| 2023 | $1,120 | 66 | Janssen Pharmaceuticals, Inc ($255.22) |
| 2022 | $704.99 | 43 | Janssen Pharmaceuticals, Inc ($174.61) |
| 2021 | $889.22 | 67 | Kowa Pharmaceuticals America, Inc. ($132.01) |
| 2020 | $1,138 | 81 | Lilly USA, LLC ($197.62) |
| 2019 | $636.49 | 81 | Novo Nordisk Inc ($117.66) |
| 2018 | $1,105 | 109 | Novo Nordisk Inc ($222.46) |
| 2017 | $1,584 | 140 | Novartis Pharmaceuticals Corporation ($255.55) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 26 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/07/2017 | Lilly USA, LLC | HUMALOG (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Diabetes | ||||||
| 02/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/06/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/31/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $101.00 | General |
| Category: DIABETES | ||||||
| 01/31/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Endocrinology | ||||||
| 01/31/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: DIABETES | ||||||
| 01/30/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Diabetes | ||||||
| 01/24/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/23/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), MOVANTIK | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $89.72 | General |
| Category: Diabetes | ||||||
| 01/17/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: DIABETES | ||||||
| 01/03/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/03/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,056 | 3,586 | $251,926 | $114,611 |
| 2022 | 44 | 2,419 | 5,265 | $308,151 | $148,111 |
| 2021 | 54 | 3,040 | 6,728 | $380,817 | $186,849 |
| 2020 | 52 | 3,464 | 7,088 | $391,786 | $177,593 |
Total Patients
10,979
Total Services
22,667
Medicare Billing
$627,164
Procedure Codes
186
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 479 | $89,100 | $37,793 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $26,840 | $14,546 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 118 | $14,750 | $6,867 | 46.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 117 | $16,614 | $6,764 | 40.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 74 | $13,616 | $6,606 | 48.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 22 | $8,778 | $4,464 | 50.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 160 | 265 | $9,275 | $4,299 | 46.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 55 | $5,156 | $3,874 | 75.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 149 | 240 | $5,280 | $3,114 | 59.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $8,592 | $3,029 | 35.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 169 | 377 | $6,032 | $2,861 | 47.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 160 | 275 | $9,350 | $2,846 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 178 | 468 | $2,808 | $2,752 | 98.0% |
| 77067 | Screening mammography | Office | 2023 | 23 | 23 | $5,244 | $1,857 | 35.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 35 | 48 | $3,312 | $1,813 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 58 | $2,088 | $1,625 | 77.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 23 | $2,944 | $1,385 | 47.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 92 | 156 | $2,496 | $1,280 | 51.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 15 | 15 | $2,775 | $1,200 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 76 | 116 | $2,204 | $1,082 | 49.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 103 | $4,944 | $990.70 | 20.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 15 | 20 | $1,160 | $580.20 | 50.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 31 | 36 | $900.00 | $517.22 | 57.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 14 | 14 | $1,652 | $475.58 | 28.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $891.00 | $420.09 | 47.1% |
About Dr. Hugh Ashurst, MD
Dr. Hugh Ashurst, MD is a Internal Medicine healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952309965.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hugh Ashurst, MD has received a total of $8,065 in payments from pharmaceutical and medical device companies, with $887.65 received in 2024. These payments were reported across 641 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,015).
As a Medicare-enrolled provider, Ashurst has provided services to 10,979 Medicare beneficiaries, totaling 22,667 services with total Medicare billing of $627,164. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mobile, AL
- Active Since 07/13/2005
- Last Updated 05/18/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952309965
Products in Payments
- XARELTO (Drug) $787.26
- ENTRESTO (Drug) $689.48
- Ozempic (Drug) $431.71
- FARXIGA (Drug) $383.57
- JARDIANCE (Drug) $276.91
- Kerendia (Drug) $267.06
- CHANTIX (Drug) $261.74
- TRULICITY (Drug) $247.06
- JANUVIA (Drug) $236.50
- XIFAXAN (Drug) $216.46
- Livalo (Drug) $199.31
- SPRAVATO (Drug) $194.24
- SOLIQUA 100/33 (Biological) $182.58
- EVENITY (Biological) $177.74
- UBRELVY (Drug) $160.09
- VRAYLAR (Drug) $158.13
- ELIQUIS (Drug) $147.91
- LEQVIO (Drug) $142.76
- INVOKANA (Drug) $128.27
- BASAGLAR (Drug) $127.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mobile
Phillip Henderson, D.o, D.O
Internal Medicine — Payments: $581,808
Internal Medicine $581,808
Thomas Mckelvey, Md, MD
Internal Medicine — Payments: $525,947
Internal Medicine $525,947
Dr. Mary Honkanen, Md, MD
Internal Medicine — Payments: $479,092
Internal Medicine $479,092
Bobby Wrights, Md, MD
Internal Medicine — Payments: $126,247
Internal Medicine $126,247
Dr. Rahel Aziz, Md, MD
Internal Medicine — Payments: $39,226
Internal Medicine $39,226
Dr. Wilburn Bolton, M.d, M.D
Internal Medicine — Payments: $36,214
Internal Medicine $36,214